
Douglas J Totten, MD, MBA
447 posts

Douglas J Totten, MD, MBA
@DouglasJTotten
ENT PGY-5 @IUSM_Oto | Alum: @VUMedicine, @VanderbiltOwen, @CarletonCollege | Marathoner | Views my own
Indianapolis, IN Katılım Şubat 2019
1.1K Takip Edilen597 Takipçiler

@jarvis_best One William Woods was telling the truth. The other was living his life
economist.com/interactive/18…
from The Economist
English


@MattCarlsonMD What is the inclusion of CN XII weakness (absent in Vernet) and the absence of ipsilateral Horner’s (present in Villaret)? (Trying to keep the form of a question/JeopEARdy theme haha)
English

@MattCarlsonMD @alexdsweeney @haynes_ear @headmirror_com @_backtableENT @WannaGeorge What is Collet-Sicard syndrome?
English
Douglas J Totten, MD, MBA retweetledi

@3YearLetterman @BDSA_students @Adele @GameOfThrones @IAMLenaHeadey @lenadunham @MacaroniGrill @BustaRhymes @mikepompeo @jiffylube @Whitesnake Pretty sure @UKFootball has 2 SEC championships. 1950 and 1976!
English
Douglas J Totten, MD, MBA retweetledi

Douglas J Totten, MD, MBA retweetledi

Excited to share our new study finding that the quality of subgroup analyses and claims for differential treatment effects in modern phase III oncology trials remains low, increasing risk of misinterpretation. More use of frameworks such as ICEMAN may improve future quality.
JAMA Network Open@JAMANetworkOpen
Subgroup analyses are common in oncology trials. However, a new study of 379 phase III trials suggests most claims for differential treatment effects in subgroup analyses have low credibility. ja.ma/3ISNIWa @MDAndersonNews @AlexSherryMD @PavlosMsaouel @PavlosMsaouel
English

@SickosCommittee @ProfessorShakey It’s a college. In a town called Northfield. Home of “Cows, Colleges, and Contentment.” Which also hosts its rival and this year’s victor, @CarletonCollege
athletics.carleton.edu/news/2023/10/7…
English

We gotta talk about some of these design choices, Minnesota.




Sickos Committee@SickosCommittee
Time for the next chapter in "NCAA college football logos over a state outline." Next up - Minnesota! Part 1 of 7.
English
Douglas J Totten, MD, MBA retweetledi

It's a Match!!! We proudly welcome our newest residents to the @IUMedSchool Otolaryngology Residency Program! 👏👏👏
#IUSchoolofMedicine
#MatchDay2024
#OtoMatch2024

English





















